The investigation and diagnosis of pathogenic mitochondrial DNA mutations in human urothelial cells

Biochemical and Biophysical Research Communications

Volumn 393, Issue 4, 2010, Pages 740-745

  Blackwood, John K ^a   Whittaker, Roger G ^a   Blakely, Emma L ^a   Alston, Charlotte L ^a   Turnbull, Douglass M ^a   Taylor, Robert W ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Heteroplasmy; MELAS; Mitochondrial DNA (mtDNA); mtDNA rearrangements; Non invasive diagnosis; Urothelial cells

Indexed keywords

MITOCHONDRIAL DNA; TRANSFER RNA;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENE DELETION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UROTHELIUM;

DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; FLUORESCENCE; GENETIC COUNSELING; GENETIC TESTING; HUMANS; MITOCHONDRIAL DISEASES; POINT MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE DELETION; UROTHELIUM;

EID: 77949487939     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.02.072     Document Type: Article

References (35)

1. Lightowlers R.N., Chinnery P.F., Turnbull D.M., et al. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet. 13 (1997) 450-455
2. Taylor R.W., and Turnbull D.M. Mitochondrial DNA mutations in human disease. Nat. Rev. Genet. 6 (2005) 389-402
3. Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348 (1990) 651-653
4. Greaves L.C., and Taylor R.W. Mitochondrial DNA mutations in human disease. IUBMB Life 58 (2006) 143-151
5. Chinnery P.F., Howell N., Lightowlers R.N., et al. Molecular pathology of MELAS and MERRF, the relationship between mutation load and clinical phenotypes. Brain 120 (1997) 1713-1721
6. Holt I.J., Harding A.E., and Morgan-Hughes J.A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331 (1988) 717-719
7. Pyle A., Taylor R.W., Durham S.E., et al. Depletion of mitochondrial DNA in leucocytes harbouring the 3243A>G mtDNA mutation. J. Med. Genet. 44 (2007) 69-74
8. Rahman S., Poulton J., Marchington D., et al. Decrease of 3243 A>G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. Am. J. Hum. Genet. 68 (2001) 238-240
9. t Hart L.M., Jansen J.J., Lemkes H.H., et al. Heteroplasmy levels of a mitochondrial gene mutation associated with diabetes mellitus decrease in leucocyte DNA upon aging. Hum. Mutat. 73 (1996) 193-197
10. Leu(UUR) A>G(3243) mutation. A clinical and genetic study. Brain 118 (1995) 721-734
11. Shanske S., Pancrudo J., Kaufmann P., et al. Varying loads of the mitochondrial DNA A3243G mutation in different tissues: implications for diagnosis. Am. J. Med. Genet. 130A (2004) 134-137
12. Sue C.M., Quigley A., Katsabanis S., et al. Detection of MELAS A3243G point mutation in muscle, blood and hair follicles. J. Neurol. Sci. 161 (1998) 36-39
13. McDonnell M.T., Schaefer A.M., Blakely E.L., et al. Noninvasive diagnosis of the 3243A>G mitochondrial DNA mutation using urinary epithelial cells. Eur. J. Hum. Genet. 12 (2004) 778-781
14. Whittaker R.G., Blackwood J.K., Alston C.L., et al. Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A>G mtDNA mutation. Neurology 72 (2009) 568-569
15. Zeviani M., Amati P., Bresolin N., et al. Rapid detection of the A>G(8344) mutation of mtDNA in Italian families with myoclonus epilepsy and ragged-red fibers (MERRF). Am. J. Hum. Genet. 48 (1991) 203-211
16. Murphy J.L., Blakely E.L., Schaefer A.M., et al. Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain 131 (2008) 2832-2840
17. He L., Chinnery P.F., Durham S.E., et al. Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR. Nucleic Acids Res. 30 (2002) e68
18. Krishnan K.J., Bender A., Taylor R.W., et al. A multiplex real-time PCR method to detect and quantify mitochondrial DNA deletions in individual cells. Anal. Biochem. 370 (2007) 127-129
19. Lys mutation in mitochondrial DNA in MERRF patients. Neurology 43 (1993) 1198-1200
20. Schaefer A.M., Phoenix C., Elson J.L., et al. Mitochondrial disease in adults: a scale to monitor progression and treatment. Neurology 66 (2006) 1932-1934
21. Lys A>G(8344) mitochondrial DNA mutation in a case of myoclonus epilepsy and ragged red fibres. Acta Neuropathol. 90 (1995) 328-333
22. Elson J.L., Swalwell H., Blakely E.L., et al. Pathogenic mitochondrial tRNA mutations: which mutations are inherited and why?. Hum. Mutat. 30 (2009) E984-E992
23. Auré K., Ogier de Baulny H., Laforêt P., et al. Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression?. Brain 130 (2007) 1516-1524
24. Phe gene mutation associated with late-onset neuromuscular disease. Arch. Neurol. 63 (2006) 902-905
25. Val gene mutation. J. Neurol. Sci. 225 (2004) 99-103
26. Ile (A4267G) mutation in a sporadic patient with mitochondrial myopathy. Neuromuscul. Disord. 12 (2002) 659-664
27. Ile gene: studies in a patient presenting with chronic progressive external ophthalmoplegia and multiple sclerosis. Biochem. Biophys. Res. Commun. 243 (1998) 47-51
28. Swalwell H., Deschauer M., Hartl H., et al. Pure myopathy associated with a novel mitochondrial tRNA gene mutation. Neurology 66 (2006) 447-449
29. Ala mutation is pathogenic and causes a phenotype of pure myopathy. Neuromuscul. Disord. 18 (2008) 63-67
30. Swalwell H., Blakely E.L., Sutton R., et al. A homoplasmic mtDNA variant can influence the phenotype of the pathogenic m.7472Cins MTTS1 mutation: are two mutations better than one?. Eur. J. Hum. Genet. 16 (2008) 1265-1274
31. Lys mutation. J. Neurol. 254 (2007) 1283-1285
32. His gene. Neurology 62 (2004) 1420-1423
33. Al-Dosary M., Whittaker R.G., Haughton J., et al. Neuromuscular disease presentation with three genetic defects involving two genomes. Neuromuscul. Disord. 19 (2009) 841-944
34. Weber K., Wilson J.N., Taylor L., et al. A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am. J. Hum. Genet. 60 (1997) 373-380
35. Pro gene mutation associated with myoclonic epilepsy with ragged-red fibers and other neurological features. Arch. Neurol. 66 (2009) 399-402